☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
F2G's Olorofim Receives the US FDA's Breakthrough Therapy Designation to Treat Invasive Mold Infections in Patients with Limited o...
November 11, 2019
Sandoz to Acquire Aspen's Japanese Operations and Associated Assets for ~$440M
November 11, 2019
AstraZeneca Reports Pooled Cardiovascular Safety and Efficacy Analyses of Roxadustat in P-III Program for CKD Patients with Anaemi...
November 11, 2019
Roche Reports Results of Risdiplam in Pivotal SUNFISH Study for Patients with Type 2 or 3 Spinal Muscular Atrophy
November 11, 2019
Celgene's Reblozyl (luspatercept–aamt) Receives FDA's Approval as the First Therapy to Treat Patients with Rare Blood Disorder
November 11, 2019
Roche Reports Results of Gazyva (obinutuzumab) in P-II NOBILITY Study for Lupus Nephritis
November 11, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions